Drug Development Archives - Oncology Central Oncology Central

i
i

2 Jun 2019 Breast
ASCO19: ribociclib combined with endocrine therapy increases survival in breast cancer patients
23 May 2019 Opinion
ASCO 2019: what should you look out for?
16 May 2019 Cancer biology and pathology
Could the Darwinian approach to drug discovery be the next era for cancer treatment?
25 Apr 2019 News
One in 10 cancer patients denied drugs recommended by their doctor, study finds
2 Apr 2019 Pancreatic
AACR19: rucaparib produces clinical response in certain pancreatic cancer patients
1 Apr 2019 News
AACR19: LOXO-195 shows promise as therapy for tumors with acquired NTRK resistance
8 Mar 2019 Ask the Experts
An interview with V. Craig Jordan: breast cancer, SERMs, tamoxifen
26 Feb 2019 Pancreatic
Lynparza® significantly delays disease progression in late-stage pancreatic cancer
20 Feb 2019 News
Pembrolizumab fails to meet primary endpoint in KEYNOTE-240 liver cancer trial
7 Feb 2019 Clinical trials
Isatuximab meets primary endpoint in Phase III multiple myeloma trial
1 Feb 2019 CAR-T therapy
NICE approves CAR-T therapy Kymriah® for diffuse large B-cell lymphoma in adults
22 Jan 2019 Targeted therapies
Future Oncology: best of 2018